Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Apomorphine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Apolipoprotéine E < Apomorphine < Apoptose  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 55.
[20-40] [0 - 20][0 - 50][40-54][40-60]
Ident.Authors (with country if any)Title
002881 (2001) Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan]Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
002952 (2001) Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan
002A28 (2001) Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
002B13 (2000) S. A. Factor [États-Unis] ; D. L. Brown [États-Unis] ; E. S. Molho [États-Unis]Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's disease
002C10 (2000) Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Endogenous dopaminergic tone and dopamine agonist action
002C57 (2000) Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Apomorphine : An underutilized therapy for Parkinson's disease
002D32 (1999) A. Schrag [Royaume-Uni] ; L. Schelosky [Allemagne] ; U. Scholz [Allemagne] ; Werner Poewe [Autriche]Reduction of parkinsonian signs in patients with parkinson's disease by dopaminergic versus anticholinergic single-dose challenges
002E02 (1999) F. Stocchi [Italie] ; C. Farina [Italie] ; G. Nordera [Italie] ; S. Ruggieri [Italie]Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
002E11 (1999) M. Merello [Argentine] ; Andrew Lees (neurologue) [Royaume-Uni] ; J. Balej [Argentine] ; A. Cammarota [Argentine] ; R. Leiguarda [Argentine]GPi firing rate modification during beginning-of-dose motor deterioration following acute administration of apomorphine
002E65 (1999) E. Grünblatt [Israël] ; S. Mandel [Israël] ; T. Berkuzki [Israël] ; M. B. H. Youdim [Israël]Apomorphine protects against MPTP-induced neurotoxicity in mice
002E66 (1999) M. Merello [Argentine] ; J. Balej [Argentine] ; M. Delfino [Argentine] ; A. Cammarota [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine]Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease
002E67 (1999) E. Moro [Italie] ; A. Albanese [Italie, Suisse]Apomorphine and levodopa challenge in patients with a focal midbrain lesion
002E80 (1999) W. Ondo [États-Unis] ; C. Hunter [États-Unis] ; M. Almaguer [États-Unis] ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease
002F10 (1998) T. Van Laar [Pays-Bas] ; B. Van Hilten [Pays-Bas] ; C. Neef [Pays-Bas] ; A. W. F. Rutgers [Pays-Bas] ; S. Pavel [Pays-Bas] ; J. A. Bruijn [Pays-Bas]The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease : A histologic study
003053 (1998) M. Merello [Argentine] ; A. Cammarota [Argentine] ; M. I. Nouzeilles [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine]Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test
003079 (1998) J. D. O'Sullivan [Australie] ; A. J. Hughes [Australie]Apomorphine-induced penile erections in Parkinson's disease
003080 (1998) M. Gassen [Allemagne] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003081 (1998) M. Gassen [Israël] ; A. Gross [Israël] ; M. B. H. Youdim [Israël]Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
003097 (1998) R. B. Jr Dewey [États-Unis] ; D. M. Maraganore [États-Unis] ; J. E. Ahlskog [États-Unis] ; J. Y. Matsumoto [États-Unis]A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease
003311 (1996) F. Stocchi [Italie] ; M. F. De Pandis [Italie] ; F. A. Delfino [Italie] ; T. Anselmo [Italie] ; D. Frongillo [Italie]Transient atrial fibrillation after subcutaneous apomorphine bolus
003376 (1996) F. Tison [France] ; L. Wiart [France] ; M. Guatterie [France] ; N. Fouillet [France] ; V. Lozano [France] ; P. Henry [France] ; M. Barat [France]Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease

List of associated Author.i

Nombre de
documents
Descripteur
7Andrew Lees (neurologue)
3A. Cammarota
3C. Neef
3M. B. H. Youdim
3M. Merello
3Olivier Rascol
3R. Leiguarda
3T. Van Laar
3Werner Poewe
2A. Gross
2A. J. Hughes
2Alice J. Manson
2Christine Brefel-Courbon
2Claudia Trenkwalder
2F. Stocchi
2Giuseppe De Michele
2J. Balej
2J. G. Nutt
2J. Hildebrand
2L. Schelosky
2M. Danhof
2M. Gassen
2Monique Galitzky
2O. Betti
2Paolo Barone
2Pierre Pollak
2R. A. C. Roos
2S. Przedborski
2S. T. Gancher
2Svenja Happe
2W. R. Woodward
2Walter Paulus
1A. Albanese
1A. B. Naini
1A. Liard
1A. Muratorio
1A. Schrag
1A. W. F. Rutgers
1Alan R. Crossman
1Albert Planas Cornes
1Alberto Albanese
1Alessandro Mauro
1Alfonso Castro Garcia
1Amy Todd
1Andrea Brioschi
1Andrew Evans
1Andrew Hughes
1Angel Sesar Ignacio
1Angela Deutschl Nder
1Angélique Gerdelat-Mas
1Anna Espino Ibanez
1Anne-Marie Bonnet
1Aranzazu Gorospe Onisalde
1B. Kleedorfer
1B. Van Hilten
1Begona Ares Pensado
1Belén Castano Garcia
1Berengere Debilly
1Berta Pascual Sedano
1Brian Henry
1Bruno Bergamasco
1Bérengère Debilly
1C. Bouchard
1C. Farina
1C. Hunter
1C. Marquardt
1C. Raftopoulos
1C.-L. Gervason
1Caridad Valero Merino
1Carlo Colosimo
1Carme Junque
1Carmine Vitale
1Cherry Ann James
1Christine Brefel
1Claire Thalamas
1D. Frongillo
1D. L. Brown
1D. Le Bars
1D. M. Maraganore
1Dagmar Kubova
1David Peggs
1Dolores Mateo Gonzalez
1Dolores Sevillano Garcia
1Dulce Campos Blanco
1E. Broussolle
1E. Grünblatt
1E. Moro
1E. N. H. Jansen
1E. S. Molho
1Eduardo Tolosa
1Eldad Melamed
1Elena Lezcano Garcia
1Elena Marelli
1Elena Munoz Fargas
1Emmanuelle Bondon-Guitton
1Estelle Dellapina
1F. A. Delfino
1F. Lavenne
1F. Mauguiere
1F. Tison

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Apomorphine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Apomorphine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024